Bridges, Alexander J.

A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 806

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901

Barrett, S. D., Bridges, A. J., Dudley, D. T., Saltiel, A. R., Fergus, J. H., Flamme, C. M., Delaney, A. M., Kaufman, M., LePage, S., Leopold, W. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters

Melanoma and MAPK PathwaysHeterocyclic Compound Synthesis and Bioactivity

Cited by 289

Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family

Smaill, J. B., Gonzales, A. J., Spicer, J. A., Lee, H., Reed, J. E., Sexton, K., Althaus, I. W., Zhu, T., Black, S. L., Blaser, A., et al. (2016) · Journal of Medicinal Chemistry

HER2/EGFR in Cancer ResearchQuinazolinone synthesis and applications

Cited by 63